Clinical trial
An Observational Study of Genetic Cardiomyopathy, Danon Disease
NCT06214507 is registered in ClinicalTrials.gov with Rocket Pharmaceuticals Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Genetic Cardiomyopathy, Danon Disease
- Lead sponsor
- Rocket Pharmaceuticals Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 20, 2023
- Completion date
- March 31, 2030
- Enrollment
- 60 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
danon disease